Cord Blood Registry

Cord Blood Registry® has earned the reputation as the Gold Standard in Cord Blood Banking.

Experience - Our laboratory has been processing cord blood stem cells for more than 10 years. More than two dozen of our samples have been used in transplant, the ultimate validation of our processing methods. Most importantly, all samples have been proven viable.

Accreditation - Cbr is accredited by the American Association of Blood Banks (AABB) for the specialized processing of stem cells.

Recognition - More than 10,000 caregivers have collected cord blood for our clients at over 2,000 birthing centers throughout the United States and in more than fifty countries. Our reputation for quality, integrity, and outstanding customer service has made us the most trusted name in cord blood banking. We have been profitable since 1999, so families can rest assured that their baby's stem cells will be available if they are needed in the future.

After you enroll, you will receive a collection kit with all the items you and your doctor will need. Cord Blood Registry® will assign you a unique identifier that will track your baby's cord blood stem cells through the entire banking process.

Collection - Once your baby is born and the umbilical cord blood has been clamped and cut, your doctor will draw blood from the cord before it is discarded. Cord Blood Registry's goal is to help your doctor collect as much cord blood as possible.

Shipment - The collection kit is pre-addressed and ready for shipment to our laboratory in Tucson, Arizona. The kit is specifically designed to meet all regulatory requirements for shipping blood and to ensure that the package is insulated and padded to protect the sample from any damage.

Processing and Banking - Cord Blood Registry is accredited by the American Association of Blood Banks (AABB), which ensures that samples are screened, processed, and cryogenically stored according to the strictest quality assurance guidelines. Red blood cells are removed before storage to minimize the risk of blood type incompatibility, and to increase the yield of viable cells.